Author:
Averina O. A.,Kuznetsova S. A.,Permyakov O. A.,Sergiev P. V.
Reference117 articles.
1. Reardon S. 2020. Step aside CRISPR, RNA editing is taking off. Nature.
578, 24–27.
2. Lada A.G., Krick C.F., Kozmin S.G., Mayorov V.I., Karpova T.S., Rogozin I.B., Pavlov Y.I. 2011. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast. Biochemistry (Moscow). 76, 131–146.
3. Kohli R.M., Maul R.W., Guminski A.F., McClu-re R.L., Gajula K.S., Saribasak H., McMahon M.A., Siliciano R.F., Gearhart P.J., Stivers J.T. 2010. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification. J. Biol. Chem.
285, 40956–40964.
4. Conticello S.G. 2008. The AID/APOBEC family of nucleic acid mutators. Genome Biol.
9, 229.
5. Komor A.C., Kim Y.B., Packer M.S., Zuris J.A., Liu D.R. 2016. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 533, 420–424.